| Quarterly Financials | Mar 2015 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 830 | 1,044 | 1,404 | 1,394 | 1,308 | 1,193 | 1,493 | 1,438 | 1,466 | 1,748 | 1,763 | 1,721 | 1,812 | 1,997 | 2,007 | 2,510 | 2,571 | 2,343 | 1,935 | 1,821 | 2,017 | 1,859 | 1,995 | 1,950 | 2,382 | 2,197 | 2,444 | 2,401 | 2,671 |
| Expenses | 501 | 643 | 802 | 827 | 851 | 776 | 955 | 902 | 945 | 1,030 | 1,008 | 1,010 | 1,072 | 1,109 | 1,169 | 1,396 | 1,414 | 1,406 | 1,234 | 1,299 | 1,464 | 1,274 | 1,430 | 1,366 | 1,572 | 1,496 | 1,622 | 1,576 | 1,700 |
| EBITDA | 328 | 401 | 602 | 567 | 457 | 418 | 538 | 536 | 521 | 717 | 755 | 711 | 740 | 888 | 837 | 1,114 | 1,157 | 937 | 701 | 522 | 553 | 585 | 565 | 584 | 810 | 701 | 822 | 825 | 971 |
| Operating Profit % | 39 % | 35 % | 39 % | 39 % | 33 % | 33 % | 34 % | 35 % | 32 % | 40 % | 42 % | 41 % | 40 % | 43 % | 41 % | 44 % | 44 % | 38 % | 33 % | 24 % | 25 % | 28 % | 25 % | 26 % | 32 % | 29 % | 31 % | 32 % | 34 % |
| Depreciation | 45 | 42 | 42 | 43 | 42 | 44 | 46 | 47 | 50 | 56 | 61 | 68 | 70 | 73 | 77 | 80 | 81 | 85 | 86 | 87 | 87 | 93 | 95 | 95 | 95 | 97 | 99 | 99 | 107 |
| Interest | 1 | 1 | 0 | 3 | 0 | 0 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
| Profit Before Tax | 286 | 359 | 559 | 522 | 415 | 373 | 488 | 487 | 471 | 661 | 694 | 642 | 670 | 815 | 760 | 1,034 | 1,076 | 852 | 615 | 435 | 466 | 492 | 469 | 489 | 713 | 604 | 722 | 726 | 864 |
| Tax | 54 | 91 | 156 | 133 | 123 | 101 | 131 | 128 | 83 | 169 | 174 | 172 | 168 | 257 | 153 | 131 | 181 | 150 | 122 | 129 | 145 | 136 | 121 | 131 | 175 | 174 | 212 | 137 | 202 |
| Net Profit | 232 | 268 | 404 | 389 | 292 | 272 | 357 | 359 | 388 | 492 | 520 | 471 | 502 | 557 | 607 | 902 | 895 | 702 | 493 | 306 | 321 | 356 | 348 | 358 | 538 | 430 | 510 | 589 | 662 |
| EPS in ₹ | 17.40 | 10.08 | 15.21 | 14.67 | 11.00 | 10.26 | 13.44 | 13.53 | 14.62 | 18.54 | 19.57 | 17.73 | 18.91 | 20.99 | 22.84 | 33.99 | 33.70 | 26.44 | 18.60 | 11.56 | 12.09 | 13.41 | 13.11 | 13.50 | 20.25 | 16.20 | 19.20 | 22.20 | 24.93 |
Divis Laboratories
Divis Laboratories
6,790.00
+11.50
(0.17%)
There are 5 new updates from the company1 day ago
View
Market Cap
1,79,947.90 Cr
EPS
82.53
PE Ratio
82.26
Dividend Yield
0.44 %
Industry
Healthcare52 Week High
7,071.50
52 Week Low
4,395.30
PB Ratio
12.04
Debt to Equity
0.00
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from24 analysts
Company News
View All News
Divi's Laboratories: Entresto Patent Litigation Outcome Threatens Earnings1 day ago
MSN won patent litigation for Novartis' cardiac drug Entresto, allowing generic launch in US after July 15, 2025. This development could potentially reduce Divi's Laboratories' annual EBITDA by 12-13% over the next year. Entresto API contributes significantly to Divi's Custom Synthesis revenue and overall topline.
Divi's Laboratories has reported a substantial increase in exports for June and the first quarter. In June, the company's exports reached USD 98.5 million, marking a 38% year-over-year increase. For the first quarter, exports totaled USD 238 million, representing a 12% growth compared to the same period last year. These figures indicate a positive trend in the company's export performance.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,727.50 | #1 4,03,712.10 | 36.18 | #1 54,729.00 | 12.06 | #1 10,980 | -18.99 | 65.78 | |
6,790.00 | #2 1,79,947.90 | #10 82.26 | #9 9,360.00 | #10 0.89 | #7 2,117 | #4 23.05 | 54.56 | |
1,490.90 | 1,19,863.80 | 23.41 | 28,409.50 | 7.12 | 5,291 | 30.28 | 47.59 | |
3,439.60 | 1,15,237.30 | 60.77 | 11,539.40 | 11.59 | 1,911 | 10.91 | 65.04 | |
2,651.00 | 1,11,292.30 | 55.10 | 12,207.40 | 19.57 | 1,925 | -10.91 | 70.34 | |
1,260.90 | 1,04,371.50 | #1 18.97 | 33,741.20 | 12.36 | 5,725 | 21.14 | 42.53 | |
967.65 | 97,448.70 | 20.84 | 22,573.80 | 13.82 | 3,977 | -0.19 | 48.60 | |
1,950.70 | 87,964.10 | 27.16 | 22,192.10 | #1 19.94 | 3,024 | #1 112.49 | 50.09 | |
34,275.00 | 72,874.50 | 51.57 | 6,409.15 | 10.80 | 1,417 | 27.83 | 59.15 | |
1,152.00 | 66,130.10 | 19.37 | 31,378.10 | 17.55 | 3,366 | -0.50 | 52.22 |
Forecast
Actual
Growth Rate
Revenue Growth
0.89 %
Net Income Growth
-12.28 %
Cash Flow Change
-48.72 %
ROE
-17.49 %
ROCE
-14.12 %
EBITDA Margin (Avg.)
-7.03 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 4,411 | 4,902 | 6,159 | 6,786 | 8,038 | 8,536 | 10,774 | 13,375 | 14,439 | 15,470 | 16,932 |
| Fixed Assets | 1,309 | 1,439 | 1,559 | 1,996 | 2,088 | 2,782 | 3,704 | 4,325 | 4,722 | 4,739 | 6,464 |
| Current Assets | 2,772 | 3,027 | 4,011 | 4,535 | 4,650 | 4,680 | 6,175 | 8,352 | 9,312 | 9,675 | 10,081 |
| Capital Work in Progress | 218 | 264 | 444 | 120 | 492 | 920 | 711 | 470 | 212 | 778 | 1,022 |
| Investments | 733 | 803 | 1,631 | 1,889 | 1,946 | 971 | 0 | 72 | 77 | 82 | 3,236 |
| Other Assets | 2,151 | 2,397 | 2,525 | 2,781 | 3,513 | 3,863 | 6,360 | 8,508 | 9,428 | 9,871 | 0 |
| Total Liabilities | 4,411 | 4,902 | 6,159 | 6,786 | 8,038 | 8,536 | 10,774 | 13,375 | 14,439 | 15,470 | 16,932 |
| Current Liabilities | 776 | 520 | 660 | 653 | 847 | 927 | 1,113 | 1,196 | 1,101 | 1,278 | 1,452 |
| Non Current Liabilities | 141 | 89 | 142 | 208 | 234 | 299 | 367 | 451 | 571 | 621 | 511 |
| Total Equity | 3,495 | 4,293 | 5,357 | 5,925 | 6,957 | 7,310 | 9,295 | 11,728 | 12,767 | 13,571 | 14,969 |
| Reserve & Surplus | 3,469 | 4,240 | 5,304 | 5,872 | 6,904 | 7,257 | 9,242 | 11,675 | 12,714 | 13,518 | 14,916 |
| Share Capital | 27 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 3 | 0 | 13 | -17 | 23 | 41 | 1,987 | -816 | -1,045 | 193 |
| Investing Activities | -521 | -406 | -1,140 | -478 | -685 | -84 | 75 | -2,195 | -2,707 | -269 |
| Operating Activities | 826 | 1,038 | 1,150 | 776 | 954 | 1,216 | 1,947 | 1,912 | 2,459 | 1,261 |
| Financing Activities | -303 | -631 | 2 | -314 | -246 | -1,091 | -35 | -532 | -797 | -799 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 51.95 % | 51.95 % | 51.95 % | 51.95 % | 51.94 % | 51.94 % | 51.94 % | 51.94 % | 51.94 % | 51.93 % | 51.93 % | 51.92 % | 51.92 % | 51.90 % | 51.89 % | 51.89 % | 51.89 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 14.86 % | 14.68 % | 16.16 % | 17.25 % | 17.99 % | 18.01 % |
| DIIs | 12.64 % | 12.61 % | 12.64 % | 13.40 % | 13.73 % | 13.93 % | 19.54 % | 20.67 % | 21.07 % | 21.23 % | 20.97 % | 21.88 % | 22.21 % | 21.77 % | 21.06 % | 20.54 % | 20.71 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 9.28 % | 8.81 % | 8.87 % | 9.01 % | 9.27 % | 9.53 % | 9.20 % | 9.53 % | 9.61 % | 9.28 % | 9.02 % | 8.85 % | 8.69 % | 7.77 % | 7.41 % | 7.32 % | 7.17 % |
| Others | 26.14 % | 26.64 % | 26.55 % | 25.64 % | 25.06 % | 24.59 % | 19.31 % | 17.86 % | 17.37 % | 17.56 % | 18.08 % | 2.48 % | 2.50 % | 2.41 % | 2.39 % | 2.26 % | 2.22 % |
| No of Share Holders | 2,08,203 | 1,93,883 | 2,23,403 | 2,74,505 | 3,09,397 | 3,46,905 | 3,79,257 | 4,14,847 | 4,33,621 | 4,02,155 | 3,73,860 | 3,54,482 | 3,47,629 | 2,98,310 | 2,78,899 | 2,80,601 | 2,67,755 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 10 | 16 | 16 | 20 | 30 | 30 | 30 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.92 | 0.59 | 0.8 | 0.44 | 0.45 | 1.06 | 0.87 | 0.52 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Aug 2025 |  Annual General Meeting | NA | 11 Aug 2025 | 6,281.35 | 6,783.05 |
| 25 Jul 2025 |  Dividend | ₹ 30.00 /share | 25 Jul 2025 | 6,281.35 | 6,783.05 |
| 17 May 2025 |  Quarterly Result Announcement | NA | 17 May 2025 | 6,144.35 | 6,281.35 |
| 03 Feb 2025 | Quarterly Result Announcement | NA | 03 Feb 2025 | 5,824.50 | 5,622.30 |
| 09 Nov 2024 | Quarterly Result Announcement | NA | 09 Nov 2024 | 5,810.10 | 5,938.15 |
| 12 Aug 2024 | Annual General Meeting | NA | 12 Aug 2024 | 4,122.75 | 4,830.20 |
| 02 Aug 2024 | Dividend | ₹ 30.00 /share | 02 Aug 2024 | 4,122.75 | 4,921.60 |
| 11 Aug 2023 | Dividend | ₹ 30.00 /share | 11 Aug 2023 | 3,097.75 | 3,745.45 |
| 12 Aug 2022 | Dividend | ₹ 30.00 /share | 11 Aug 2022 | 4,306.60 | 3,947.80 |
| 20 Aug 2021 | Dividend | ₹ 20.00 /share | 17 Aug 2021 | 4,120.25 | 4,912.05 |
| 26 Sept 2015 |  Bonus | 1:1 | 23 Sept 2015 | 0.00 | 0.00 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15 hours ago
15 hours agoBusiness Responsibility and Sustainability Reporting (BRSR)1 day ago
1 day agoNotice Of 35Th Annual General Meeting To Be Held On August 11 20251 day ago
1 day agoReg. 34 (1) Annual Report.1 day ago
1 day agoReg. 34 (1) Annual Report.1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoClosure of Trading WindowJun 30, 2025
Jun 30, 2025Communication To Shareholders - Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2024-25May 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
May 26, 2025Intimation Of Signing Of Long-Term Manufacturing And Supply AgreementMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 17, 2025
May 17, 2025Intimation Of Appointment Of Secretarial AuditorMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 17, 2025
May 17, 2025Intimation Of AGM Date And Record Date For DividendMay 17, 2025
May 17, 2025Corporate Action-Board approves DividendMay 17, 2025
May 17, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On May 17 2025May 17, 2025
May 17, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On May 17 2025May 17, 2025
May 17, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
May 08, 2025Board Meeting Intimation for Considering And Approving Audited Financial Results For The Quarter And Year Ended March 31 2025 And Recommending Dividend For FY2024-25 If Any.May 08, 2025
May 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 30, 2025
Apr 30, 2025Intimation Of Signing Of Long-Term Manufacturing And Supply AgreementApr 18, 2025
Apr 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Mar 31, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 07, 2025
Mar 07, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 07, 2025
Mar 07, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Feb 05, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 04, 2025
Feb 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2025
Feb 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2025
Feb 03, 2025Integrated Filing (Financial)Feb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 03, 2025
Feb 03, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On February 03 2025Feb 03, 2025
Feb 03, 2025Outcome Of Board Meeting Held On February 03 2025 - Financial Results For The Quarter And Nine Months Ended December 30 2024Feb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2025
Jan 28, 2025Board Meeting Intimation for Intimation Of Board MeetingJan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Jan 13, 2025Initmation Of Commencement Of Commercial Operations At Unit III Greenfield Project At Kakinada Andhra Pradesh In Phased MannerJan 02, 2025
Jan 02, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Resubmission - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015Dec 05, 2024
Dec 05, 2024Clarification /Confirmation On News Item Appearing In 'Media/Publication' Under Regulation 30 Of SEBI (LODR) Regulations, 2015Dec 05, 2024
Dec 05, 2024Intimation Of Action(S) Taken Or Orders PassedDec 04, 2024
Dec 04, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2024
Nov 11, 2024Technical Indicators
RSI(14)
Neutral 54.56
ATR(14)
Less Volatile 131.89
STOCH(9,6)
Neutral 54.99
STOCH RSI(14)
Oversold 11.73
MACD(12,26)
Bearish -14.81
ADX(14)
Strong Trend 27.52
UO(9)
Bearish 52.54
ROC(12)
Uptrend But Slowing Down 1.98
WillR(14)
Neutral -52.86
Mutual Fund Holdings
Mirae Asset Large & Midcap Fund Direct-Growth 
SBI Equity Hybrid Fund Direct Plan-Growth 
Nippon India Pharma Fund Direct-Growth 
UTI Nifty200 Momentum 30 Index Fund Direct - Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
Quant ELSS Tax Saver Fund Direct-Growth 
HSBC Aggressive Hybrid Fund Direct-Growth 
Bajaj Finserv Large and Mid Cap Fund Direct-Growth 
Tata Arbitrage Fund Direct - Growth 
Aditya Birla Sun Life Quant Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth About Divis Laboratories
Divi's Laboratories Ltd is a leading pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals. The company operates globally with a presence in over 100 countries and has six manufacturing facilities. It offers both generic and custom synthesis services for pharmaceutical companies, supporting product development from clinical trials to market launch. Divi's Laboratories has two main subsidiaries: Divis Laboratories (USA) Inc. and Divi's Laboratories Europe AG, which focus on marketing nutraceutical products. The company has research centers in Hyderabad and at its manufacturing sites, with a focus on custom synthesis and contract research. Divi's Laboratories has expanded its operations over the years, establishing multiple manufacturing units, including special economic zones (SEZs), and has undergone various regulatory inspections and certifications. The company continues to invest in capacity expansion and infrastructure upgrades to meet growing market demands.
Listing Date
12 Mar, 2003(22 Years,
4 days)
Website
Chairperson NameRamesh B V Nimmagadda
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
